业界动态国内医卫资讯

广泛的基因组检测与NSCLC更长的生存期相关

Medscape News · 2026-11-12 22:01

摘要

一项研究探讨,与聚焦性生物标志物检测相比,治疗前进行广泛基因组测序是否能改善晚期非小细胞肺癌的生存期。Medscape Medical News

English
Broad Genomic Testing Tied to Longer Survival in NSCLC

A study examines whether broad-based genomic sequencing before treatment improves survival in advanced non-small cell lung cancer compared with focused biomarker testing. Medscape Medical News

内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界